E
Enveric Biosciences D
D
ENVB
0.64280
USD
-0.06
(-8.50%)
مغلق
حجم التداول
1,319
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
3,997,938
الأخبار المقالات
العنوان: Enveric Biosciences Inc
القطاع: Healthcare
الصناعة: Biotechnology
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.